Clinical Pharmacokinetics and Pharmacodynamics of Cholinesterase Inhibitors

被引：0
|
作者：
Michael W. Jann
Kara L. Shirley
Gary W. Small
机构：
[1] Mercer University,Department of Clinical and Administrative Sciences, Southern School of Pharmacy
[2] Albany College of Pharmacy,Department of Pharmacy Practice
[3] University of California,Department of Psychiatry and Biobehavioral Sciences, Center on Aging and Alzheimer’s Disease Research Center
[4] Mercer University,Southern School of Pharmacy
来源：
Clinical Pharmacokinetics | 2002年 / 41卷
关键词：
Cholinesterase; Fluvoxamine; Cholinesterase Inhibitor; Rivastigmine; Tacrine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cholinesterase inhibitors are the ‘first-line’ agents in the treatment of Alzheimer’s disease. This article presents the latest information on their pharmacokinetic properties and pharmacodynamic activity.
引用
收藏
页码：719 / 739
页数：20
相关论文
共 50 条
  • [21] Clinical Pharmacokinetics and Pharmacodynamics of Aliskiren
    Sujata Vaidyanathan
    Venkateswar Jarugula
    Hans Armin Dieterich
    Dan Howard
    William P. Dole
    Clinical Pharmacokinetics, 2008, 47 : 515 - 531
  • [22] Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin
    Yan-Ling He
    Clinical Pharmacokinetics, 2012, 51 : 147 - 162
  • [23] Clinical Pharmacokinetics and Pharmacodynamics of Safinamide
    Thomas Müller
    Paul Foley
    Clinical Pharmacokinetics, 2017, 56 : 251 - 261
  • [24] Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
    Teijo I. Saari
    John Strang
    Ola Dale
    Clinical Pharmacokinetics, 2024, 63 : 397 - 422
  • [25] Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
    Roeland E. Wasmann
    Eline W. Muilwijk
    David M. Burger
    Paul E. Verweij
    Catherijne A. Knibbe
    Roger J. Brüggemann
    Clinical Pharmacokinetics, 2018, 57 : 267 - 286
  • [26] Clinical pharmacokinetics and pharmacodynamics of finasteride
    Steiner, JF
    CLINICAL PHARMACOKINETICS, 1996, 30 (01) : 16 - 27
  • [27] Clinical pharmacokinetics and pharmacodynamics of repaglinide
    Hatorp, V
    CLINICAL PHARMACOKINETICS, 2002, 41 (07) : 471 - 483
  • [28] Clinical pharmacokinetics and pharmacodynamics of Aliskiren
    Vaidyanathan, Sujata
    Jarugula, Venkateswar
    Dieterich, Hans Armin
    Howard, Dan
    Dole, William P.
    CLINICAL PHARMACOKINETICS, 2008, 47 (08) : 515 - 531
  • [29] Clinical Pharmacokinetics and Pharmacodynamics of Albiglutide
    Bronden, Andreas
    Knop, Filip K.
    Christensen, Mikkel B.
    CLINICAL PHARMACOKINETICS, 2017, 56 (07) : 719 - 731
  • [30] Clinical Pharmacokinetics and Pharmacodynamics of Cefepime
    Gwendolyn M. Pais
    Jack Chang
    Erin F. Barreto
    Gideon Stitt
    Kevin J. Downes
    Mohammad H. Alshaer
    Emily Lesnicki
    Vaidehi Panchal
    Maria Bruzzone
    Argyle V. Bumanglag
    Sara N. Burke
    Marc H. Scheetz
    Clinical Pharmacokinetics, 2022, 61 : 929 - 953
12345